• Institute of Good Manufacturing Practices India
  • Global accredited training & certification provider
  • Approved by Quality Council of India (QCI) & Accredited Vocational Institution of Ministry of HRD, Government of India
  • Approved Training Institute of Food Safety and Standards Authority of India (FSSAI)
  • Recognized by Department of Industrial Policy & Promotion, Ministry of Commerce & Industry, Government of India
  • An ISO 9001:2015 Certified Organisation registered under The Societies Registration Act,1860 Government of India
  • Empanelled under Ministry of Horticulture and Food Processing, Government of Uttar Pradesh
  • Affiliated with Life Sciences and Food Industry Sector Skills Council (SSC) set up by National Skill Development Corporation (NSDC)
  • Conferred with QUALITY COUNCIL OF INDIA (QCI) – D.L. SHAH NATIONAL QUALITY AWARD & ASSOCHAM Services Excellence Award 2017

Trusted by organizations & training participants in over 30 countries
Training | Certification | Education | Research


TrialAssure has joined hands with Otsuka Pharmaceuticals to provide its Clinical Trial Disclosure Reporting System

TrialAssure is a global clinical trial disclosure and transparency reporting company which helps clients to meet regulatory compliance goals through a flexible, scalable and streamlined platform that gets regularly updated with respect to ever-changing clinical trial disclosure requirements. Otsuka Pharmaceutical Development and commercialization, Inc. is a global healthcare company based in Tokyo, Japan.

TrialAssure has partnered with Otsuka Pharmaceutical Development and commercialization, Inc. to implement its comprehensive transparency management system for all compounds in Otsuka’s drug development pipeline. TrialAssure’s proprietary clinical trial disclosure management system being a single integrated system has been designed for transparency in such a way that it will lead to removal of redundancy, workflow acceleration, improved protocol registration compliance and improved compliance with result disclosures for all Otsuka’s compounds including central nervous system and neurology, oncology and cardiovascular and renal therapeutic areas. These efficiencies of the TrialAssure’s tool will in turn help Otsuka to measure more easily performance with dashboards and KPIs, including timelines to complete trial registrations and disclosures.

A software-as-a-service (Saas) solution will be provided by TrialAssure to Otsuka which will allow their internal disclosure experts to use the built-in validation system and proven reporting tools to integrate with their master data and retool core data for application to multiple registries, meeting global reporting requirements for ClinicalTrials.gov, EudraCT and other global registries.

According to Annadoir Staveley, Associate Director of Clinical Trial Disclosure & Transparency, Otsuka, "The company recognizes the value of TrialAssure’s public registry tracking tool to help in managing Clinical Trial Disclosure requirements and responsibilities from study registration to results posting and all associated tasks."